Publications by authors named "Licio Collavin"

Claim this Profile
D
Drug-Repurposing Screen Identifies Thiostrepton as a Novel Regulator of the Tumor Suppressor DAB2IP.
Rossella De Florian Fania, Serena Maiocchi, Raffaella Klima, Monica Rossin, Valeria Pellegrini, Licio Collavin

Biomolecules· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications.
Rossella De Florian Fania, Arianna Bellazzo, Licio Collavin

Cell Death Differ· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target.
Elzbieta Panczyszyn, Valentina Saverio, Romina Monzani, Mara Gagliardi, Jelena Petrovic, Licio Collavin

Cell Death Discov· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells.
Mattia Apollonio, Arianna Bellazzo, Nicoletta Franco, Silvia Lombardi, Beatrice Senigagliesi, Licio Collavin

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management?
Marco Corazzari, Licio Collavin

Front Genet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple negative breast cancer-derived small extracellular vesicles as modulator of biomechanics in target cells.
Beatrice Senigagliesi, Giuseppe Samperi, Nicola Cefarin, Luciana Gneo, Sara Petrosino, Licio Collavin

Nanomedicine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses.
Nicoletta Caronni, Giulia Maria Piperno, Francesca Simoncello, Oriana Romano, Simone Vodret, Licio Collavin

Nat Commun· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting the Brakes on Ras-Cytoplasmic GAPs as Targets of Inactivation in Cancer.
Arianna Bellazzo, Licio Collavin

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.
Marianna Lucafò, Daria Sicari, Andrea Chicco, Debora Curci, Arianna Bellazzo, Licio Collavin

Cancer Chemother Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome.
Valeria Capaci, Lorenzo Bascetta, Marco Fantuz, Galina V Beznoussenko, Roberta Sommaggio, Licio Collavin

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant p53 improves cancer cells' resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6.
Daria Sicari, Marco Fantuz, Arianna Bellazzo, Elena Valentino, Mattia Apollonio, Licio Collavin

Oncogene· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant p53 as a guardian of the cancer cell.
Fiamma Mantovani, Licio Collavin, Giannino Del Sal

Cell Death Differ· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.
Arianna Bellazzo, Giulio Di Minin, Elena Valentino, Daria Sicari, Denis Torre, Licio Collavin

Cell Death Differ· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexes formed by mutant p53 and their roles in breast cancer.
Arianna Bellazzo, Daria Sicari, Elena Valentino, Giannino Del Sal, Licio Collavin

Breast Cancer (Dove Med Press)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP.
Arianna Bellazzo, Licio Collavin

Oncoscience· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP.
Elena Valentino, Arianna Bellazzo, Giulio Di Minin, Daria Sicari, Mattia Apollonio, Licio Collavin

Proc Natl Acad Sci U S A· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.
Arianna Bellazzo, Giulio Di Minin, Licio Collavin

Cell Death Differ· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer.
Arianna Bellazzo, Giulio Di Minin, Licio Collavin

Mol Cell Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP.
Giulio Di Minin, Arianna Bellazzo, Marco Dal Ferro, Giulia Chiaruttini, Simona Nuzzo, Licio Collavin

Mol Cell· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEP89 is required for mitochondrial metabolism and neuronal function in man and fly.
Bregje W M van Bon, Merel A W Oortveld, Leo G Nijtmans, Michaela Fenckova, Bonnie Nijhof, Licio Collavin

Hum Mol Genet· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rebel angel: mutant p53 as the driving oncogene in breast cancer.
Dawid Walerych, Marco Napoli, Licio Collavin, Giannino Del Sal

Carcinogenesis· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat.
Claudia Carrieri, Laura Cimatti, Marta Biagioli, Anne Beugnet, Silvia Zucchelli, Licio Collavin

Nature· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's disease DJ-1 L166P alters rRNA biogenesis by exclusion of TTRAP from the nucleolus and sequestration into cytoplasmic aggregates via TRAF6.
Sandra Vilotti, Marta Codrich, Marco Dal Ferro, Milena Pinto, Isidro Ferrer, Licio Collavin

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intragenic enhancers act as alternative promoters.
Monika S Kowalczyk, Jim R Hughes, David Garrick, Magnus D Lynch, Jacqueline A Sharpe, Licio Collavin

Mol Cell· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p73 as a pharmaceutical target for cancer therapy.
Andrea Bisso, Licio Collavin, Giannino Del Sal

Curr Pharm Des· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis